{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-111045","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2025-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.364479+00:00","generated_at":"2026-05-16T19:53:42.812228+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Unicycive Therapeutics increases ATM offering capacity from $50M to $100M","bullets":["Amendment No. 1 to Sales Agreement raises aggregate offering price limit from $50M to $100M.","Sales agent remains Guggenheim Securities, LLC; shares sold at market prices under Rule 415.","Company filed a prospectus supplement with the SEC on November 14, 2025, covering the increase.","Legal opinion on share validity from Sheppard Mullin filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-111045","json":"https://secwatch.observer/filing/0001213900-25-111045.json","markdown":"https://secwatch.observer/filing/0001213900-25-111045.md","text":"https://secwatch.observer/filing/0001213900-25-111045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025111045/0001213900-25-111045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025111045/ea0265675-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:53:42.812228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}